Cargando…

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir

Pimodivir exerts an antiviral effect on the early stages of influenza A virus replication by inhibiting the cap-binding function of polymerase basic protein 2 (PB2). In this study, we used a combination of sequence analysis and phenotypic methods to evaluate pimodivir susceptibility of influenza A v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Mira C., Chesnokov, Anton, Jones, Joyce, Mishin, Vasiliy P., De La Cruz, Juan A., Nguyen, Ha T., Zanders, Natosha, Wentworth, David E., Davis, Todd C., Gubareva, Larisa V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978222/ https://www.ncbi.nlm.nih.gov/pubmed/33581212 http://dx.doi.org/10.1016/j.antiviral.2021.105035

Ejemplares similares

Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
por: Mishin, Vasiliy P., et al.
Publicado: (2019)

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
por: Patel, Mira C., et al.
Publicado: (2022)

Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods
por: Patel, Mira C., et al.
Publicado: (2020)

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons
por: Gubareva, Larisa V, et al.
Publicado: (2019)

Structural and Thermodynamic Analysis of the Resistance Development to Pimodivir (VX-787), the Clinical Inhibitor of Cap Binding to PB2 Subunit of Influenza A Polymerase †
por: Gregor, Jiří, et al.
Publicado: (2021)

Comprehensive Profiling of Mutations to Influenza Virus PB2 That Confer Resistance to the Cap-Binding Inhibitor Pimodivir
por: Soh, Y. Q. Shirleen, et al.
Publicado: (2021)

Detection of oseltamivir‐resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test
por: Hodges, Erin N., et al.
Publicado: (2019)

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022
por: Nguyen, Ha T., et al.
Publicado: (2023)

Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018
por: Jorquera, Patricia A., et al.
Publicado: (2019)

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014)

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART
por: Gubareva, Larisa V, et al.
Publicado: (2017)

Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020
por: Mohan, Teena, et al.
Publicado: (2021)

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2010)

Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011
por: Nguyen, Ha T., et al.
Publicado: (2013)

Mammalian Pathogenesis and Transmission of Avian Influenza A(H7N9) Viruses, Tennessee, USA, 2017
por: Belser, Jessica A., et al.
Publicado: (2018)

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins
por: Marjuki, Henju, et al.
Publicado: (2016)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study( )
por: O’Neil, Brian, et al.
Publicado: (2020)

Mammalian pathogenicity and transmissibility of low pathogenic avian influenza H7N1 and H7N3 viruses isolated from North America in 2018
por: Belser, Jessica A., et al.
Publicado: (2020)

Update: Influenza Activity — United States and Worldwide, May 20–October 13, 2018
por: Chow, Eric J., et al.
Publicado: (2018)

Pathogenesis and transmission of human seasonal and swine-origin A(H1) influenza viruses in the ferret model
por: Pulit-Penaloza, Joanna A., et al.
Publicado: (2022)

Attenuation of highly pathogenic avian influenza A(H5N1) viruses in Indonesia following the reassortment and acquisition of genes from low pathogenicity avian influenza A virus progenitors
por: Dharmayanti, Ni Luh Putu Indi, et al.
Publicado: (2018)

Genetically Diverse Low Pathogenicity Avian Influenza A Virus Subtypes Co-Circulate among Poultry in Bangladesh
por: Gerloff, Nancy A., et al.
Publicado: (2016)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2014)

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
por: Okomo‐Adhiambo, Margaret, et al.
Publicado: (2013)

R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses
por: Sleeman, Katrina, et al.
Publicado: (2013)

Avian Influenza A(H7N2) Virus in Human Exposed to Sick Cats, New York, USA, 2016
por: Marinova-Petkova, Atanaska, et al.
Publicado: (2017)

Influenza A(H3N2) Virus in Swine at Agricultural Fairs and Transmission to Humans, Michigan and Ohio, USA, 2016
por: Bowman, Andrew S., et al.
Publicado: (2017)

Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic — China, October 2016–February 2017
por: Iuliano, A. Danielle, et al.
Publicado: (2017)

The PB2 Subunit of the Influenza A Virus RNA Polymerase Is Imported into the Mitochondrial Matrix
por: Long, Joshua C. D., et al.
Publicado: (2016)

TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase
por: Fu, Bishi, et al.
Publicado: (2015)

A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses
por: De Marco, Donata, et al.
Publicado: (2012)

Role of the PB2 627 Domain in Influenza A Virus Polymerase Function
por: Nilsson, Benjamin E., et al.
Publicado: (2017)

Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit
por: Ma, Xiaolei, et al.
Publicado: (2017)

Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans
por: Soh, YQ Shirleen, et al.
Publicado: (2019)

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020
por: Govorkova, Elena A., et al.
Publicado: (2022)

Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface
por: Yuan, Shuofeng, et al.
Publicado: (2017)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
por: Hurt, Aeron C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pn2vvq4ko0of4fc9705uvjaslk